title: Intrathecal use of amikacin: a case report.
abstract: Meningitis caused by Acinetobacter baumannii is rare and are mostly hospital acquired after neurosurgical procedure. We report a case of a 40-year old man was admitted to the intensive care unit due to subarachnoid haemorrhage. Our patient developed a ventriculitis due to A.baumannii treated successfully with sulbactam IV and intrathecal amikacin.
authors.affiliation: Reanimation Anaesthesia Department, Ibn Rochd University Hospital, Casablanca, Morocco.
authors.forename: L
authors.initials: L
authors.lastname: Barrou
authors.forename: B
authors.initials: B
authors.lastname: Charra
authors.forename: A
authors.initials: A
authors.lastname: Hachimi
authors.forename: B
authors.initials: B
authors.lastname: Idali
authors.forename: A
authors.initials: A
authors.lastname: Benslama
authors.forename: S
authors.initials: S
authors.lastname: Motaouakkil
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000209:etiology; D040981:Acinetobacter baumannii; D000328:Adult; D000583:Amikacin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003399:Craniotomy / Q000009:adverse effects; D017809:Fatal Outcome; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000209:etiology; D013345:Subarachnoid Hemorrhage / Q000601:surgery; D013407:Sulbactam / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D000583:Amikacin; D013407:Sulbactam